ABBVIE INC (4AB.DE) Fundamental Analysis & Valuation

FRA:4AB • US00287Y1091

Current stock price

175.15 EUR
-1.5 (-0.85%)
Last:

This 4AB.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. 4AB.DE Profitability Analysis

1.1 Basic Checks

  • In the past year 4AB was profitable.
  • 4AB had a positive operating cash flow in the past year.
  • 4AB had positive earnings in each of the past 5 years.
  • Each year in the past 5 years 4AB had a positive operating cash flow.
4AB.DE Yearly Net Income VS EBIT VS OCF VS FCF4AB.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.12%, 4AB is in the better half of the industry, outperforming 70.24% of the companies in the same industry.
  • 4AB's Return On Invested Capital of 14.42% is amongst the best of the industry. 4AB outperforms 88.10% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 4AB is in line with the industry average of 13.21%.
  • The 3 year average ROIC (12.12%) for 4AB is below the current ROIC(14.42%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.12%
ROE N/A
ROIC 14.42%
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
4AB.DE Yearly ROA, ROE, ROIC4AB.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100 -100

1.3 Margins

  • 4AB has a Profit Margin of 6.84%. This is in the better half of the industry: 4AB outperforms 70.24% of its industry peers.
  • In the last couple of years the Profit Margin of 4AB has declined.
  • 4AB has a better Operating Margin (34.23%) than 88.10% of its industry peers.
  • In the last couple of years the Operating Margin of 4AB has grown nicely.
  • With a decent Gross Margin value of 71.62%, 4AB is doing good in the industry, outperforming 61.90% of the companies in the same industry.
  • 4AB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 34.23%
PM (TTM) 6.84%
GM 71.62%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
4AB.DE Yearly Profit, Operating, Gross Margins4AB.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

3

2. 4AB.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 4AB is creating some value.
  • 4AB has about the same amout of shares outstanding than it did 1 year ago.
  • 4AB has about the same amout of shares outstanding than it did 5 years ago.
  • 4AB has a worse debt/assets ratio than last year.
4AB.DE Yearly Shares Outstanding4AB.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
4AB.DE Yearly Total Debt VS Total Assets4AB.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • 4AB has an Altman-Z score of 2.29. This is not the best score and indicates that 4AB is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of 4AB (2.29) is comparable to the rest of the industry.
  • The Debt to FCF ratio of 4AB is 3.79, which is a good value as it means it would take 4AB, 3.79 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 3.79, 4AB is doing good in the industry, outperforming 78.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.79
Altman-Z 2.29
ROIC/WACC1.68
WACC8.58%
4AB.DE Yearly LT Debt VS Equity VS FCF4AB.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B

2.3 Liquidity

  • A Current Ratio of 0.67 indicates that 4AB may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.67, 4AB is doing worse than 82.14% of the companies in the same industry.
  • A Quick Ratio of 0.56 indicates that 4AB may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.56, 4AB is doing worse than 82.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.56
4AB.DE Yearly Current Assets VS Current Liabilites4AB.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

4

3. 4AB.DE Growth Analysis

3.1 Past

  • The earnings per share for 4AB have decreased by -1.19% in the last year.
  • 4AB shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.99% yearly.
  • Looking at the last year, 4AB shows a quite strong growth in Revenue. The Revenue has grown by 8.57% in the last year.
  • Measured over the past years, 4AB shows a small growth in Revenue. The Revenue has been growing by 5.95% on average per year.
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.08% on average over the next years. This is quite good.
  • Based on estimates for the next years, 4AB will show a small growth in Revenue. The Revenue will grow by 6.43% on average per year.
EPS Next Y48.29%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue Next Year10.06%
Revenue Next 2Y9.09%
Revenue Next 3Y8.46%
Revenue Next 5Y6.43%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4AB.DE Yearly Revenue VS Estimates4AB.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B
4AB.DE Yearly EPS VS Estimates4AB.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

7

4. 4AB.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 20.65 indicates a rather expensive valuation of 4AB.
  • Based on the Price/Earnings ratio, 4AB is valued a bit cheaper than the industry average as 79.76% of the companies are valued more expensively.
  • 4AB's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.33.
  • With a Price/Forward Earnings ratio of 13.93, 4AB is valued correctly.
  • 4AB's Price/Forward Earnings ratio is rather cheap when compared to the industry. 4AB is cheaper than 90.48% of the companies in the same industry.
  • 4AB's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 38.16.
Industry RankSector Rank
PE 20.65
Fwd PE 13.93
4AB.DE Price Earnings VS Forward Price Earnings4AB.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 4AB is valued a bit cheaper than the industry average as 77.38% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, 4AB is valued cheaper than 86.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.51
EV/EBITDA 14.73
4AB.DE Per share data4AB.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40

4.3 Compensation for Growth

  • 4AB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 4AB has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as 4AB's earnings are expected to grow with 22.01% in the coming years.
PEG (NY)0.43
PEG (5Y)N/A
EPS Next 2Y28.1%
EPS Next 3Y22.01%

6

5. 4AB.DE Dividend Analysis

5.1 Amount

  • 4AB has a Yearly Dividend Yield of 3.26%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.70, 4AB pays a better dividend. On top of this 4AB pays more dividend than 94.05% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, 4AB pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.26%

5.2 History

  • On average, the dividend of 4AB grows each year by 6.76%, which is quite nice.
Dividend Growth(5Y)6.76%
Div Incr Years5
Div Non Decr Years5
4AB.DE Yearly Dividends per share4AB.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 2 4 6

5.3 Sustainability

  • 278.48% of the earnings are spent on dividend by 4AB. This is not a sustainable payout ratio.
  • The dividend of 4AB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP278.48%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
4AB.DE Yearly Income VS Free CF VS Dividend4AB.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B
4AB.DE Dividend Payout.4AB.DE Dividend Payout, showing the Payout Ratio.4AB.DE Dividend Payout.PayoutRetained Earnings

4AB.DE Fundamentals: All Metrics, Ratios and Statistics

ABBVIE INC

FRA:4AB (4/15/2026, 5:12:39 PM)

175.15

-1.5 (-0.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-04
Earnings (Next)04-29
Inst Owners76.21%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap309.80B
Revenue(TTM)61.16B
Net Income(TTM)4.19B
Analysts77.95
Price Target218.65 (24.84%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.26%
Yearly Dividend5.63
Dividend Growth(5Y)6.76%
DP278.48%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.46%
Min EPS beat(2)0.18%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.25%
Min EPS beat(4)0.18%
Max EPS beat(4)2.75%
EPS beat(8)8
Avg EPS beat(8)1.12%
EPS beat(12)10
Avg EPS beat(12)0.74%
EPS beat(16)12
Avg EPS beat(16)0.58%
Revenue beat(2)0
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)-0.78%
Revenue beat(4)2
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)5
Avg Revenue beat(12)0.03%
Revenue beat(16)5
Avg Revenue beat(16)-0.64%
PT rev (1m)0.95%
PT rev (3m)2.68%
EPS NQ rev (1m)-0.68%
EPS NQ rev (3m)-4.28%
EPS NY rev (1m)-0.08%
EPS NY rev (3m)2.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.49%
Valuation
Industry RankSector Rank
PE 20.65
Fwd PE 13.93
P/S 5.97
P/FCF 20.51
P/OCF 19.2
P/B N/A
P/tB N/A
EV/EBITDA 14.73
EPS(TTM)8.48
EY4.84%
EPS(NY)12.57
Fwd EY7.18%
FCF(TTM)8.54
FCFY4.88%
OCF(TTM)9.12
OCFY5.21%
SpS29.32
BVpS-1.57
TBVpS-43.89
PEG (NY)0.43
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 3.12%
ROE N/A
ROCE 23.09%
ROIC 14.42%
ROICexc 15.28%
ROICexgc N/A
OM 34.23%
PM (TTM) 6.84%
GM 71.62%
FCFM 29.13%
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
ROICexc(3y)13.19%
ROICexc(5y)12.96%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.1%
ROCE(5y)18.64%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y5.79%
ROICexc growth 5Y14.56%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
F-Score8
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.79
Debt/EBITDA 2.11
Cap/Depr 14.92%
Cap/Sales 1.98%
Interest Coverage 6.97
Cash Conversion 65.45%
Profit Quality 425.61%
Current Ratio 0.67
Quick Ratio 0.56
Altman-Z 2.29
F-Score8
WACC8.58%
ROIC/WACC1.68
Cap/Depr(3y)11.82%
Cap/Depr(5y)10.58%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.55%
Profit Quality(3y)434.7%
Profit Quality(5y)340.33%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
EPS Next Y48.29%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%
Revenue Next Year10.06%
Revenue Next 2Y9.09%
Revenue Next 3Y8.46%
Revenue Next 5Y6.43%
EBIT growth 1Y26.92%
EBIT growth 3Y1.33%
EBIT growth 5Y8.87%
EBIT Next Year42.08%
EBIT Next 3Y19.31%
EBIT Next 5Y10.21%
FCF growth 1Y-0.09%
FCF growth 3Y-9.76%
FCF growth 5Y1.19%
OCF growth 1Y1.19%
OCF growth 3Y-8.62%
OCF growth 5Y1.59%

ABBVIE INC / 4AB.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ABBVIE INC (4AB.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to 4AB.DE.


What is the valuation status for 4AB stock?

ChartMill assigns a valuation rating of 7 / 10 to ABBVIE INC (4AB.DE). This can be considered as Undervalued.


Can you provide the profitability details for ABBVIE INC?

ABBVIE INC (4AB.DE) has a profitability rating of 7 / 10.


How financially healthy is ABBVIE INC?

The financial health rating of ABBVIE INC (4AB.DE) is 3 / 10.


What is the earnings growth outlook for ABBVIE INC?

The Earnings per Share (EPS) of ABBVIE INC (4AB.DE) is expected to grow by 48.29% in the next year.